Literature DB >> 11571358

Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA.

S Orimo1, E Ozawa, T Oka, S Nakade, K Tsuchiya, M Yoshimoto, K Wakabayashi, H Takahashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11571358     DOI： 10.1212/wnl.57.6.1140

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  20 in total

1.  Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.

Authors:  David S Goldstein; Courtney Holmes; Patti Sullivan; Deborah C Mash; Ellen Sidransky; Alessandro Stefani; Irwin J Kopin; Yehonatan Sharabi
Journal:  Parkinsonism Relat Disord       Date:  2015-07-17       Impact factor: 4.891

2.  Neuroscience and heart-brain medicine: the year in review.

Authors:  David S Goldstein
Journal:  Cleve Clin J Med       Date:  2010-07       Impact factor: 2.321

3.  Diagnosis of dementia with Lewy bodies: can 123I-IMP and 123I-MIBG scintigraphy yield new core features?

Authors:  Fumi Sakamoto; Shinya Shiraishi; Noriko Tsuda; Mamoru Hashimoto; Seiji Tomiguchi; Manabu Ikeda; Yasuyuki Yamashita
Journal:  Br J Radiol       Date:  2016-11-29       Impact factor: 3.039

Review 4.  Dysautonomia in Parkinson disease.

Authors:  David S Goldstein
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

5.  Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.

Authors:  Masashi Suzuki; Tomohiko Nakamura; Masaaki Hirayama; Miki Ueda; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2016-11-29       Impact factor: 4.849

6.  Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.

Authors:  David S Goldstein; Courtney Holmes; Yehonatan Sharabi
Journal:  Brain       Date:  2012-03-26       Impact factor: 13.501

7.  Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson's disease.

Authors:  K Hamada; M Hirayama; H Watanabe; R Kobayashi; H Ito; T Ieda; Y Koike; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-04       Impact factor: 10.154

Review 8.  Sympathetic neuroimaging.

Authors:  David S Goldstein
Journal:  Handb Clin Neurol       Date:  2013

9.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

10.  Orthostatic hypotension as an early finding in Parkinson's disease.

Authors:  David S Goldstein
Journal:  Clin Auton Res       Date:  2006-02       Impact factor: 4.435
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.